Ask Your Colleagues About:

Treatment Strategies
 

CMV retinitis and ARv

Posted: Aug 31, 2007

QUESTION:

Hello I have a 37year-old patient with a CD4 cell count on 325 and CMV retinitis (I have never seen a CMV retinitis with so much CD4 cells). I will start valganciclovir in an ambulatory basis as soon as I get it . He is otherwise in good clinical condition. I will also start ARV but I have doubts about when to start: right now or after induction therapy with valganciclovir. Another question: how long should I keep him on mainteinance therapy with valganciclovir as he starts with 325 CD4s? Which parameter should I use? Clinical improvement?


  

RESPONSE FROM:   

    CMV retinitis is rare at higher CD4 cell counts but not unheard of. It would be interesting to know the CD4%. If this is low, I would follow the CD4% when determining the duration of maintenance therapy. Certainly a CD4% over 14% would be a minimal level to consider discontinuation.

    If the CD4% is not too bad, I might consider valganciclovir at 900 mg daily indefinitely. One could arbitrarily think of stopping at some high level such as a CD4 count of 500.

    I would start ART but would probably wait until after induction therapy with valganciclovir is completed.

    DW




Terms of Use: Please remember that this forum is designed for educational purposes only, and experts are not engaged through this forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body PRO, Body Health Resources Corporation or any sponsor of this forum.

Visitors submitting questions remain solely responsible for the content of their messages. Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as legal or other professional advice. This information is not a substitute for professional advice or care.

powered by ExpertViewpoint